Technology
Health
Pharmaceutical
Kiniksa Pharmaceuticals
$14.049876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$14.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.30 (2.17%) As of 3:05 PM EDT today
+$0.30 (2.17%) Today
Why Robinhood?
You can buy or sell KNSA and other stocks, options, ETFs, and crypto commission-free!
About KNSA
Kiniksa Pharmaceuticals, Ltd. Class A Common Stock, also called Kiniksa Pharmaceuticals, is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Read More Its products include Rilonacept, Mavrilimumab, KPL-716, KPL-045, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason, and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Hamilton, Bermuda.
Employees
111
Headquarters
Hamilton, Hamilton
Founded
2015
Market Cap
751.48M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
118.79K
High Today
$14.50
Low Today
$13.79
Open Price
$13.90
Volume
35.91K
52 Week High
$32.88
52 Week Low
$13.04
Collections
Technology
Health
Pharmaceutical
Biopharmaceutical
Medical
2018 IPO
North America (Non-US/Canada)
North America
Price Paid on Robinhood
16% Lower
Right Now
52 Week Low
$13.04
Average Price Paid
$16.81
52 Week High
$32.88
KNSA Earnings
-$1.27
-$0.99
-$0.72
-$0.44
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 5, Pre-Market